The future of one of President Joe Biden's key domestic policy achievements — getting Medicare to negotiate drug prices — could either become part of the Biden administration's legacy, get rolled back ...

DEA and HHS ended an impasse over the virtual prescribing of controlled substances that threatened access to drugs like Adderall by extending pandemic-era flexibilities through the end of 2025.